Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss FATE - Fate Therapeutics, Inc.
15 K
LAST VALUE
42.12%
2 YEAR CAGR
56.87%
5 YEAR CAGR
7.21%
10 YEAR CAGR